e.l.f Beauty Shares Plunge. Should Investors Buy the Stock on the Dip or Stay Away?

e.l.f. Beauty (ELF) shares plummeted over 40% year-to-date following its fiscal Q2 report, where sales of $344 million missed consensus and full-year 2026 revenue and EPS guidance significantly underperformed analyst expectations, despite Q2 adjusted EPS beating estimates. The company attributed the miss to temporary shipment holdbacks related to a price increase and higher tariffs, which impacted gross margins. However, the article suggests the market's reaction was extreme, noting e.l.f.'s historically conservative guidance, the long-term growth potential from the Rhode acquisition, upcoming shelf space gains, and an attractive valuation with a 17.5x forward P/E and 0.3 PEG ratio, implying a potential buying opportunity.

Analysis

e.l.f. Beauty (ELF) shares plummeted over 40% year-to-date following its fiscal Q2 2026 report, despite adjusted EPS of $0.68 beating the $0.57 consensus. Q2 sales of $344 million missed analyst expectations of $366 million, attributed to temporary shipment holdbacks related to a price increase. Full-year FY26 revenue guidance of $1.55 billion to $1.57 billion (18-20% growth) and adjusted EPS of $2.80 to $2.85 both significantly underperformed consensus estimates.

The guidance miss was impacted by an average 60% tariff on 75% of products made in China, causing a 165 basis point decline in gross margins to 69%. SG&A expenses increased to 56% of revenues, reflecting ongoing investments, with marketing spend projected to rise to 27-29% of net sales in H2 FY26. Conversely, the Rhode acquisition is anticipated to contribute $200 million in FY26 revenue, with an annual run rate of $300 million, driving approximately 40% growth.

Despite near-term challenges, the long-term narrative for e.l.f. appears robust, supported by management's historically conservative guidance and projected organic sales growth of 3-4% for FY26. Upcoming shelf space gains at Ulta Beauty and substantial growth potential from the Rhode brand further bolster the outlook. The stock's current valuation, with a forward P/E of 17.5x (FY27 estimates) and a forward PEG ratio of 0.3, suggests potential undervaluation, implying the market's reaction may have been excessive.

Key Decisions for Investors

• Investors should consider the recent stock decline as a potential buying opportunity, given the attractive 0.3 forward PEG ratio and management's historically conservative guidance.
• Monitor the integration and growth trajectory of the Rhode acquisition, which is projected to contribute significantly to future revenue and organic growth.
• Evaluate the impact of tariffs and rising SG&A on future profitability, alongside the effectiveness of increased marketing spend in driving sales.
• Watch for updates on shelf space gains at Ulta Beauty and international expansion, which are key drivers for long-term organic growth.